The effect of metformin and diet on metabolic syndrome treatment
Phase 2
- Conditions
- metabolic syndrome.Endocrine, nutritional and metabolic diseasesE00-E90
- Registration Number
- IRCT2013052013399N1
- Lead Sponsor
- Vice-Chancellery of Research and Technology, Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Having 3 characteristics related to metabolic syndrome according to ATPIII ( Adult Treatment Panel): waist Circumference =40 (men) or =35 inches (women), Blood Pressure =135 (systole) or =85 (diastole) mmHg, Fasting Blood Sugar =100mg/dl, Triglycerides =150mg/dl, and High-Density Lipoproteins <40 (men) or <50 mg/dl (women). Of course the waist circumference size for Asian men is =90 cm and for Asian women is =58 cm. Not taking any drug that might affect blood pressure and glucose , insulin or lipid metabolism . Not having diabetes, liver or kidney diseases .
Exclusion criteria: Patients will be excluded if they get gastrointestinal disorders or lose their interest to continue the study.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Weight. Timepoint: before the intervention, 8weeks after the intervention. Method of measurement: seca weighing machine.;Blood pressure. Timepoint: before intervention ,8weeks after intervention. Method of measurement: mmgh-piezometer.;Lipid profile (TG,HDL,LDL,total Chol). Timepoint: before intervention,8weeks after intervention. Method of measurement: biosystem autoanalyzer bt1500.;Fasting blood sugar. Timepoint: before the intervention, 8 weeks after the intervention. Method of measurement: biosystem autoanalyzer bt1500.;Waist circumference. Timepoint: before intervention ,8weeks after intervention. Method of measurement: centimeter-tape measure.
- Secondary Outcome Measures
Name Time Method